1. Home
  2. MNMD vs VSTS Comparison

MNMD vs VSTS Comparison

Compare MNMD & VSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNMD
  • VSTS
  • Stock Information
  • Founded
  • MNMD 2019
  • VSTS 1936
  • Country
  • MNMD United States
  • VSTS United States
  • Employees
  • MNMD N/A
  • VSTS N/A
  • Industry
  • MNMD Pharmaceuticals and Biotechnology
  • VSTS
  • Sector
  • MNMD Health Care
  • VSTS
  • Exchange
  • MNMD Nasdaq
  • VSTS Nasdaq
  • Market Cap
  • MNMD 709.9M
  • VSTS 819.7M
  • IPO Year
  • MNMD N/A
  • VSTS N/A
  • Fundamental
  • Price
  • MNMD $9.61
  • VSTS $4.15
  • Analyst Decision
  • MNMD Strong Buy
  • VSTS Sell
  • Analyst Count
  • MNMD 7
  • VSTS 4
  • Target Price
  • MNMD $24.71
  • VSTS $9.13
  • AVG Volume (30 Days)
  • MNMD 1.1M
  • VSTS 1.6M
  • Earning Date
  • MNMD 11-06-2025
  • VSTS 08-05-2025
  • Dividend Yield
  • MNMD N/A
  • VSTS 1.72%
  • EPS Growth
  • MNMD N/A
  • VSTS N/A
  • EPS
  • MNMD N/A
  • VSTS N/A
  • Revenue
  • MNMD N/A
  • VSTS $2,707,109,000.00
  • Revenue This Year
  • MNMD N/A
  • VSTS N/A
  • Revenue Next Year
  • MNMD N/A
  • VSTS $0.25
  • P/E Ratio
  • MNMD N/A
  • VSTS N/A
  • Revenue Growth
  • MNMD N/A
  • VSTS N/A
  • 52 Week Low
  • MNMD $4.70
  • VSTS $3.98
  • 52 Week High
  • MNMD $11.02
  • VSTS $17.83
  • Technical
  • Relative Strength Index (RSI)
  • MNMD 53.63
  • VSTS 37.51
  • Support Level
  • MNMD $8.70
  • VSTS $4.04
  • Resistance Level
  • MNMD $10.04
  • VSTS $4.27
  • Average True Range (ATR)
  • MNMD 0.50
  • VSTS 0.21
  • MACD
  • MNMD 0.00
  • VSTS 0.02
  • Stochastic Oscillator
  • MNMD 73.88
  • VSTS 19.75

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

Share on Social Networks: